These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25807422)

  • 1. Flavoxate: present and future.
    Arcaniolo D; Conquy S; Tarcan T
    Eur Rev Med Pharmacol Sci; 2015; 19(5):719-31. PubMed ID: 25807422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis.
    Sweeney P; Mutambirwa S; Van An N; Sharma JB; Vanamail P
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3703-12. PubMed ID: 27649675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
    Roxburgh C; Cook J; Dublin N
    Cochrane Database Syst Rev; 2007 Jul; (3):CD003190. PubMed ID: 17636716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
    Roxburgh C; Cook J; Dublin N
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003190. PubMed ID: 17943782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavoxate in urogynecology: an old drug revisited.
    Zor M; Aydur E; Dmochowski RR
    Int Urogynecol J; 2015 Jul; 26(7):959-66. PubMed ID: 25480503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.
    Asimakopoulos AD; Cerruto MA; Del Popolo G; La Martina M; Artibani W; Carone R; Finazzi-Agrò E
    Urol Int; 2012; 89(3):259-69. PubMed ID: 22777274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women.
    Robinson JM; Brocklehurst JC
    Br J Urol; 1983 Aug; 55(4):371-6. PubMed ID: 6349743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
    Stewart F; Gameiro LF; El Dib R; Gameiro MO; Kapoor A; Amaro JL
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010098. PubMed ID: 27935011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
    Stewart F; Gameiro OL; El Dib R; Gameiro MO; Kapoor A; Amaro JL
    Cochrane Database Syst Rev; 2016 Apr; 4():CD010098. PubMed ID: 27037009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
    Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
    Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor urge incontinence: diagnosis and treatment.
    Gaudenz R; Weil A
    Urol Int; 1980; 35(1):1-12. PubMed ID: 7361347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavoxate hydrochloride in the treatment of detrusor instability.
    Delaere KP; Michiels HG; Debruyne FM; Moonen WA
    Urol Int; 1977; 32(5):377-81. PubMed ID: 610033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of flavoxate hydrochloride in the treatment of urge incontinence.
    Ruffmann R
    J Int Med Res; 1988; 16(5):317-30. PubMed ID: 2461883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and tolerability of mirabegron in patients aged ≥65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR).
    Wagg A; Staskin D; Engel E; Herschorn S; Kristy RM; Schermer CR
    Eur Urol; 2020 Feb; 77(2):211-220. PubMed ID: 31733990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using flavoxate as primary medication for patients suffering from urge symptomatology.
    Fehrmann-Zumpe P; Karbe K; Blessman G
    Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(2):91-5. PubMed ID: 10384969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the combination emepronium bromide/flavoxate and emepronium bromide in the treatment of detrusor instability.
    Aagaard J; Reuther K; Stimpel H
    Urol Int; 1983; 38(3):191-2. PubMed ID: 6868218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex.
    Chapple CR; Mironska E; Wagg A; Milsom I; Diaz DC; Koelbl H; Pushkar D; Tubaro A; De Ridder D; Chartier-Kastler E; Phillips LD
    Eur Urol Focus; 2020 May; 6(3):522-530. PubMed ID: 31623981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of an α
    Herschorn S; Tarcan T; Jiang YH; Chung E; Abdul Hadi F; Steup A; Sumarsono B
    Neurourol Urodyn; 2024 Mar; 43(3):604-619. PubMed ID: 38291827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.